PL1831191T3 - Pochodne chromanu i ich zastosowanie jako ligandów receptorów 5-HT - Google Patents
Pochodne chromanu i ich zastosowanie jako ligandów receptorów 5-HTInfo
- Publication number
- PL1831191T3 PL1831191T3 PL05822998T PL05822998T PL1831191T3 PL 1831191 T3 PL1831191 T3 PL 1831191T3 PL 05822998 T PL05822998 T PL 05822998T PL 05822998 T PL05822998 T PL 05822998T PL 1831191 T3 PL1831191 T3 PL 1831191T3
- Authority
- PL
- Poland
- Prior art keywords
- receptor ligands
- chroman derivatives
- chroman
- derivatives
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
- C07D313/02—Seven-membered rings
- C07D313/06—Seven-membered rings condensed with carbocyclic rings or ring systems
- C07D313/08—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/12—Antiepileptics; Anticonvulsants for grand-mal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US63785404P | 2004-12-21 | 2004-12-21 | |
| EP05822998A EP1831191B1 (en) | 2004-12-21 | 2005-12-12 | Chroman derivatives and their use as 5-ht receptor ligands |
| PCT/EP2005/013291 WO2006066746A1 (en) | 2004-12-21 | 2005-12-12 | Chroman derivatives and their use as 5-ht receptor ligands |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1831191T3 true PL1831191T3 (pl) | 2008-10-31 |
Family
ID=35929640
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL05822998T PL1831191T3 (pl) | 2004-12-21 | 2005-12-12 | Pochodne chromanu i ich zastosowanie jako ligandów receptorów 5-HT |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US7759389B2 (pl) |
| EP (1) | EP1831191B1 (pl) |
| JP (1) | JP2008524275A (pl) |
| KR (1) | KR20070088798A (pl) |
| CN (1) | CN101124212A (pl) |
| AT (1) | ATE396183T1 (pl) |
| AU (1) | AU2005318596B2 (pl) |
| BR (1) | BRPI0516381A (pl) |
| CA (1) | CA2592001A1 (pl) |
| DE (1) | DE602005007064D1 (pl) |
| ES (1) | ES2306275T3 (pl) |
| MX (1) | MX2007007480A (pl) |
| PL (1) | PL1831191T3 (pl) |
| RU (1) | RU2396264C2 (pl) |
| WO (1) | WO2006066746A1 (pl) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7842713B2 (en) * | 2006-04-20 | 2010-11-30 | Pfizer Inc | Fused phenyl amido heterocyclic compounds |
| CN102216276A (zh) | 2008-09-11 | 2011-10-12 | 辉瑞大药厂 | 取代的杂芳基物 |
| BRPI1013246B1 (pt) * | 2009-03-11 | 2019-10-01 | Pfizer, Inc. | Derivados de benzofuranila, suas composições farmacêuticas e seus usos |
| CN101838274B (zh) * | 2009-05-21 | 2012-03-28 | 浙江医药股份有限公司新昌制药厂 | 一种d-生物素的改进制备方法 |
| CN102869255B (zh) * | 2010-02-12 | 2016-08-31 | 内瓦利斯治疗公司 | S-亚硝基谷胱甘肽还原酶的新抑制剂 |
| WO2011146089A1 (en) * | 2010-05-21 | 2011-11-24 | Abbott Laboratories | Modulators of 5-ht receptors and methods of use thereof |
| CN103649079B (zh) | 2010-12-22 | 2016-11-16 | Abbvie公司 | 丙型肝炎抑制剂及其用途 |
| CN110981844A (zh) * | 2019-12-19 | 2020-04-10 | 江南大学 | 一种亚砜类黄酮和砜类黄酮的制备方法 |
| CN111072617A (zh) * | 2019-12-19 | 2020-04-28 | 江南大学 | 一种8-苯磺酰基取代的黄酮醇的制备方法 |
| CN111039998A (zh) * | 2019-12-19 | 2020-04-21 | 江南大学 | 一种8-苯磺酰基取代的黄酮葡萄糖糖苷的制备方法 |
| CN113214231B (zh) * | 2020-01-21 | 2022-04-08 | 瀚远医药有限公司 | 5ht2a受体拮抗剂及其医疗应用 |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3901814A1 (de) * | 1988-07-28 | 1990-02-01 | Bayer Ag | Substituierte aminomethylzetraline sowie ihre heterocyclischen analoga |
| IL109647A (en) * | 1989-02-27 | 1997-04-15 | Lilly Co Eli | Intermediate compounds for ring-substituted 2-amino-1, 2, 3, 4-tetra- hydronaphthalenes and 3-aminochromanes |
| US5506192A (en) * | 1990-06-07 | 1996-04-09 | Sandoz Ltd. | Substituted phthalides and heterocyclic phthalides |
| EP0541807B1 (en) * | 1990-07-27 | 1997-12-17 | Chugai Seiyaku Kabushiki Kaisha | Novel benzopyran derivative |
| US5401848A (en) | 1990-11-26 | 1995-03-28 | E. R. Squibb & Sons, Inc. | Indane and quinoline derivatives |
| US5817693A (en) * | 1991-11-05 | 1998-10-06 | Cousins; Russell Donovan | Endothelin receptor antagonists |
| ZA93436B (en) * | 1992-01-24 | 1993-08-25 | Chugai Pharmaceutical Co Ltd | Benzopyran derivatives |
| KR100231634B1 (ko) * | 1992-08-17 | 1999-11-15 | 나가야마 오사무 | 벤조피란 및 벤족사진 유도체 |
| US5374643A (en) * | 1992-09-11 | 1994-12-20 | E. R. Squibb & Sons, Inc. | Aryl urea (thiourea) and cyanoguanidine derivatives |
| US5739135A (en) * | 1993-09-03 | 1998-04-14 | Bristol-Myers Squibb Company | Inhibitors of microsomal triglyceride transfer protein and method |
| US6150402A (en) * | 1994-08-15 | 2000-11-21 | Loma Linda University Medical Center | Natriuretic compounds |
| US5869478A (en) | 1995-06-07 | 1999-02-09 | Bristol-Myers Squibb Company | Sulfonamido substituted benzopyran derivatives |
| JPH11509532A (ja) | 1995-06-30 | 1999-08-24 | ファルマシア・アンド・アップジョン・カンパニー | 片頭痛治療用の１，６−二置換イソクロマン |
| US5663194A (en) * | 1995-07-25 | 1997-09-02 | Mewshaw; Richard E. | Chroman-2-ylmethylamino derivatives |
| US5935958A (en) * | 1996-07-01 | 1999-08-10 | Schering Corporation | Muscarinic antagonists |
| WO1998007418A1 (en) | 1996-08-21 | 1998-02-26 | Smithkline Beecham Corporation | Il-8 receptor antagonists |
| US6559144B2 (en) * | 1997-02-13 | 2003-05-06 | Merck Patent Gesellschaft Mit | Bicyclic amino acids |
| CA2276278C (en) * | 1997-02-27 | 2009-04-07 | Takeda Chemical Industries, Ltd. | Amine compounds, their production and use |
| TWI242011B (en) * | 1997-03-31 | 2005-10-21 | Eisai Co Ltd | 1,4-substituted cyclic amine derivatives |
| FR2778662B1 (fr) * | 1998-05-12 | 2000-06-16 | Adir | Nouveaux composes cycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| US6479536B1 (en) * | 1998-12-04 | 2002-11-12 | Takeda Chemical Industries, Ltd. | Benzofuran derivatives, process for the preparation of the same and uses thereof |
| CN100349872C (zh) * | 2000-04-03 | 2007-11-21 | 武田药品工业株式会社 | 制备胺衍生物的方法 |
| AR035858A1 (es) * | 2001-04-23 | 2004-07-21 | Bayer Corp | Derivados de cromano 2,6-sustituidos,composiciones farmaceuticas,uso de dichos derivados para la manufactura de medicamentos utiles como agonistas adrenorreceptores beta-3 |
| MXPA04001089A (es) * | 2001-08-03 | 2004-05-20 | Upjohn Co | 5-arilsulfonil indoles que tienen afinidad por el receptor de 5-ht. |
| WO2003029239A1 (en) * | 2001-10-04 | 2003-04-10 | Wyeth | Chroman and benzofuran derivatives as 5-hydroxytryptamine-6 ligands |
| EP1432696A1 (en) * | 2001-10-04 | 2004-06-30 | Wyeth | Chroman derivatives as 5-hydroxytryptamine-6 ligands |
| US7943639B2 (en) * | 2002-06-20 | 2011-05-17 | Proximagen Limited | Compounds |
| US7795242B2 (en) * | 2003-10-15 | 2010-09-14 | The Brigham And Women's Hospital, Inc. | Methods and compositions for immunomodulation |
| EP1678121A4 (en) | 2003-10-24 | 2007-07-25 | Exelixis Inc | MODULATORS OF TAO KINASES AND METHODS OF USE |
-
2005
- 2005-12-12 CA CA002592001A patent/CA2592001A1/en not_active Abandoned
- 2005-12-12 JP JP2007547254A patent/JP2008524275A/ja not_active Ceased
- 2005-12-12 PL PL05822998T patent/PL1831191T3/pl unknown
- 2005-12-12 AT AT05822998T patent/ATE396183T1/de active
- 2005-12-12 WO PCT/EP2005/013291 patent/WO2006066746A1/en active IP Right Grant
- 2005-12-12 EP EP05822998A patent/EP1831191B1/en not_active Not-in-force
- 2005-12-12 DE DE602005007064T patent/DE602005007064D1/de active Active
- 2005-12-12 MX MX2007007480A patent/MX2007007480A/es active IP Right Grant
- 2005-12-12 KR KR1020077016602A patent/KR20070088798A/ko active Search and Examination
- 2005-12-12 CN CNA2005800485143A patent/CN101124212A/zh active Pending
- 2005-12-12 AU AU2005318596A patent/AU2005318596B2/en not_active Ceased
- 2005-12-12 ES ES05822998T patent/ES2306275T3/es active Active
- 2005-12-12 BR BRPI0516381-1A patent/BRPI0516381A/pt not_active IP Right Cessation
- 2005-12-12 RU RU2007123251/04A patent/RU2396264C2/ru not_active IP Right Cessation
- 2005-12-21 US US11/315,392 patent/US7759389B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006066746A1 (en) | 2006-06-29 |
| EP1831191A1 (en) | 2007-09-12 |
| EP1831191B1 (en) | 2008-05-21 |
| AU2005318596B2 (en) | 2010-12-23 |
| RU2396264C2 (ru) | 2010-08-10 |
| MX2007007480A (es) | 2007-07-20 |
| ES2306275T3 (es) | 2008-11-01 |
| KR20070088798A (ko) | 2007-08-29 |
| AU2005318596A1 (en) | 2006-06-29 |
| US7759389B2 (en) | 2010-07-20 |
| CA2592001A1 (en) | 2006-06-29 |
| US20060148888A1 (en) | 2006-07-06 |
| CN101124212A (zh) | 2008-02-13 |
| ATE396183T1 (de) | 2008-06-15 |
| DE602005007064D1 (de) | 2008-07-03 |
| JP2008524275A (ja) | 2008-07-10 |
| BRPI0516381A (pt) | 2008-09-02 |
| RU2007123251A (ru) | 2009-01-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL1831191T3 (pl) | Pochodne chromanu i ich zastosowanie jako ligandów receptorów 5-HT | |
| PL1831152T3 (pl) | Pochodne tetraliny i indanu oraz ich zastosowanie jako antagonistów 5-HT | |
| TW200633964A (en) | Tetralin and indane derivatives and uses thereof | |
| WO2007147771A3 (en) | Tetralin and indane derivatives and uses thereof | |
| NO20084915L (no) | Nikotinacetylcholinreseptorligander 101 | |
| MX2007006387A (es) | Derivados de piridina 3-substituidos como antagonistas h3. | |
| GEP20104964B (en) | 3-aminocarbazole compounds, pharmaceutical composition containing the same and method for the preparation thereof | |
| MY186650A (en) | Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives | |
| DE602004009200D1 (de) | Tetrahydrochinazolinderivate als cfr-antagonisten | |
| MY139612A (en) | Benzoxazine derivatives as 5-th6 modulators and uses thereof | |
| MX2007007027A (es) | Derivados piperazinilpiridina como agentes anti-obesidad. | |
| TW200738697A (en) | Benzimidazole derivatives as 5-HT6,5-HT24 | |
| MY136824A (en) | Substituted benzoxazinones and uses thereof | |
| MX2009004898A (es) | Derivados de indol y de benzofurano-2-carboxamida. | |
| SI1893589T1 (sl) | Substituirani N-benzo(d)izoksazol-3-il-aminski derivati kot inhibitorji mGluR5, serotonin-(5-HT) in noradrenalinskih receptorjev in njihova uporaba za pripravo zdravil | |
| MXPA05009523A (es) | Derivados de quinolina/benzoxazinona y sus usos. | |
| WO2006061126A3 (en) | Dibenzoxazepinone derivatives | |
| IL188927A0 (en) | Aryloxy quinolines and uses thereof as 5-ht6 modulators | |
| WO2007123942A3 (en) | Benzodioxane and benzodioxolane derivatives and uses thereof | |
| TW200626567A (en) | Benzoxazine and quinoxaline derivatives and uses | |
| WO2003076426A3 (en) | Pyridinyloxy derivatives as 5-ht receptor ligands | |
| MX2009001572A (es) | Derivados de arilpiperazina y usos de los mismos. | |
| MX2007007485A (es) | Derivados de cromano y usos de los mismos en el tratamiento de trastornos del sistema nervioso central. | |
| IL181666A0 (en) | Indolin-2-one pyridine derivatives, preparation and therapeutic use thereof | |
| TW200611900A (en) | Process for the preparation of 3-amino-8-(1-piperazinyl)-2H-1-benzopyran-2-one and salts and solvates thereof |